Therapy insight: Vascular complications in patients with inflammatory bowel disease

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 2, Issue 6, 2005, Pages 266-272

  Koutroubakis, Ioannis E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Antiphospholipid antibodies; Crohn's disease; Homocysteine; Thromboembolism; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; ESTROGEN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; PHOSPHOLIPID ANTIBODY; STEROID; STREPTOKINASE; UROKINASE; WARFARIN; XIMELAGATRAN;

ARTERY THROMBOSIS; BLEEDING; BLOOD CLOTTING; DEEP VEIN THROMBOSIS; ENTERITIS; FAMILY HISTORY; FIBRINOLYSIS; GENE MUTATION; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; LEG THROMBOSIS; LUNG EMBOLISM; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SIDE EFFECT; THROMBECTOMY; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM; GENETICS; MASS SCREENING; PATHOPHYSIOLOGY; THROMBOEMBOLISM; THROMBOPHILIA; VASCULAR DISEASE; VEIN THROMBOSIS;

HUMANS; INFLAMMATORY BOWEL DISEASES; MASS SCREENING; PULMONARY EMBOLISM; THROMBOEMBOLISM; THROMBOPHILIA; VASCULAR DISEASES; VENOUS THROMBOSIS;

EID: 21244487777     PISSN: 17434378     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpgasthep0190     Document Type: Review

References (55)

1. Talbot RW et al. (1986) Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61: 140-145
2. Solem CA et al. (2004) Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 99: 97-101
3. Hatoum OA and Binion DG (2005) The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflam Bowel Dis 11: 304-313
4. Danese S et al. (2003) Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 52: 1435-1441
5. Levy PJ et al. (1997) Lower extremity arterial occlusions in young patients with Crohn's colitis and premature atherosclerosis: report of six cases. Am J Gastroenterol 92: 494-497
6. Nuutinen H et al. (1995) Association of ulcerative colitis and ischemic heart disease [abstract]. Gastroenterology 108: a886
7. Nuutinen H et al. (1996) Association of Crohn's disease and ischemic heart disease [abstract]. Gastroenterology 110: a981
8. Ruby AJ and Jampol LM (1990) Crohn's disease and retinal vascular disease. Am J Ophthalmol 110: 349-353
9. Sato R et al. (1994) Takayasu's disease associated with ulcerative colitis. Intern Med 33: 759-763
10. Bargen JA and Barker NW (1936) Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 58: 17-31
11. Koutroubakis IE (2001) Unraveling the mechanisms of thrombosis in inflammatory bowel disease. Am J Gastroenterol 96: 1325-1327
12. Koutroubakis IE (2000) Role of thrombotic risk factors in inflammatory bowel disease. Dig Dis 18: 161-167
13. Graef V et al. (1965) Venous thrombosis occuring in non-specific ulcerative colitis. Arch Intern Med 117: 377-382
14. Miehsler W et al. (2004) Is inflammatory bowel disease an independent and disease-specific risk factor for thromboembolism? Gut 53: 542-548
15. Bernstein CN et al. (2001) The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 85: 430-434
16. Grip O et al. (2000) Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 35: 619-623
17. Esmon CT (2003) Inflammation and thrombosis. J Thromb Haemost 1: 1343-1348
18. Stadnicki A et al. (1997) Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis. Dig Dis Sci 42: 2356-2366
19. van Bodegraven AA et al. (2002) Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis. Eur J Gastroenterol Hepatol 14: 413-418
20. van Bodegraven AA (2003) Haemostasis in inflammatory bowel diseases: clinical relevance. Scand J Gastroenterol 239 (Suppl): S51-S62
21. Saibeni S et al. (2004) Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Am J Gastroenterol 99: 1966-1970
22. Danese S et al. (2004) Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 99: 938-945
23. Koutroubakis IE et al. (2004) Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol 16: 1147-1152
24. Wakefield AJ et al. (1989) Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 2: 1057-1062
25. Wakefield AJ et al. (1991) Granulomatous vasculitis in Crohn's disease. Gastroenterology 100: 1279-1287
26. Thompson NP et al. (1995) Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 108: 1011-1015
27. Gaffney PR et al. (1995) Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 90: 220-223
28. Torkvist L et al. (1999) Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther 13: 1323-1328
29. Weijl NI et al. (2000) Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. J Clin Oncol 18: 2169-2178
30. Mijnhout GS et al. (2004) Sepsis and elevated liver enzymes in a patient with inflammatory bowel disease: think of portal vein thrombosis. Dig Liver Dis 36: 296-300
31. Junge U et al. (2001) Acute Budd-Chiari syndrome, portal and splenic vein thrombosis in a patient with ulcerative colitis associated with antiphospholipid antibodies and protein C deficiency. Z Gastroenterol 39: 845-852
32. Fichera A et al. (2003) Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain. Dis Colon Rectum 46: 643-648
33. Novotny DA et al. (1992) Arterial thromboembolic complications of inflammatory bowel disease. Report of three cases. Dis Colon Rectum 35: 193-196
34. Szychta P et al. (2001) Aortic thrombosis and ulcerative colitis. Ann Vasc Surg 15: 402-404
35. Ashkan K et al. (1998) Arterial thrombosis: a complication of loop ileostomy. Eur J Gastroenterol Hepatol 10: 795-796
36. Novacek G et al. (2004) Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literature. Inflamm Bowel Dis 10: 430-435
37. Efremidis M et al. (1999) Acute myocardial infarction in a young patient during an exacerbation of ulcerative colitis. Int J Cardiol 70: 211-212
38. Papa A et al. (2003) Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 98: 1247-1251
39. Vecchi M et al. (2000) Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 45: 1465-1469
40. Guédon C et al. (2001) Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol 96: 1448-1454
41. Koutroubakis IE et al. (1998) Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci 43: 2507-2512
42. Aichbichler BW et al. (1999) Anti-cardiolipin antibodies in patients with inflammatory bowel disease. Dig Dis Sci 44: 852-856
43. Oldenburg B et al. (2005) Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia. Dig Dis Sci 50: 235-240
44. Koutroubakis IE et al. (2001) Increased levels of Lipoprotein (a) in Crohn's disease: a relation to thrombosis? Eur J Gastroenterol Hepatol 13: 1415-1419
45. Koutroubakis IE et al. (2000) Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol 95: 190-194
46. Liebman HA et al. (1998) The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 115: 830-834
47. Papa A et al. (2000) Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease. Blood Coagul Fibrinolysis 11: 499-503
48. Cattaneo M et al. (1998) High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost 80: 542-545
49. Koutroubakis IE et al. (2000) Hyperhomocysteinemia in Greek patients with inflammatory bowel disease. Dig Dis Sci 45: 2347-2351
50. Morgenstern I et al. (2003) Homocysteine, cysteine, and glutathione in human colonic mucosa: elevated levels of homocysteine in patients with inflammatory bowel disease. Dig Dis Sci 48: 2083-2090
51. Mahmud N et al. (1999) Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45: 389-394
52. Danese S et al. (2005) Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 100: 886-895
53. Turpie AG et al. (2002) ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies. BMJ 325: 948-950
54. Kao A et al. (2002) Anticoagulation therapy in cerebral sinovenous thrombosis and ulcerative colitis in children. J Child Neurol 17: 479-482
55. Lengle SJ et al. (1995) Arterial thrombosis in ulcerative colitis: transcatheter thrombolytic therapy. West J Med 162: 543-547